Company: GRCE
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001140361-25-041804
Chunk: 36

Company: Grace Therapeutics, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Item 8
Chunk 36
---
, 2024.

   General and administrative expenses

   General and administrative expenses consist primarily of salaries and related benefits, including stock-based compensation, related to our executive, finance, legal, and support functions, including professional fees for auditing, tax, consulting, rent and utilities and insurance.

We expect our general and
administrative expenses to continue to increase for the foreseeable future as
we continue to advance our research and development programs, grow our business
and prepare for possible commercial launch if GTx-104 receives marketing
approval.

   (expressed in thousands)

    Three months ended

      Six months ended

      September 30, 2025

      September 30, 2024

      Increase (Decrease)

      September 30, 2025

      September 30, 2024

      Increase (Decrease)

    $ 
      $ 
      $ 
      $ 
      $ 
      $ 

      Salaries and benefits

    448 
      490 
      (42) 
      922 
      885 
      37 

      Professional fees

    987 
      977 
      10 
      1,862 
      2,431 
      (569) 

    Other   
    379 
      244 
      135 
      929 
      476 
      453 

      General and administrative expense before stock-based compensation and depreciation1

    1,814 
      1,711 
      103 
      3,713 
      3,792 
      (79) 

      Stock-based compensation

    146 
      142 
      4 
      380 
      314 
      66 

      Depreciation and loss on disposal

    1 
      2 
      (1) 
      3 
      3 
                    —            

      Total

    1,961 
      1,855 
      106 
      4,096 
      4,109 
      (13) 

   1 General and administrative sub-total expenses are calculated before stock-based compensation and depreciation.

   General and administrative expenses were